AEGiS-ST: Disease stifles young woman's ambitions Sunday Times (Johannesburg)Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Click here to return to Sunday Times (Johannesburg) main menu
DonateNow
Print this article

Disease stifles young woman's ambitions

Sunday Times (Johannesburg) - September 10, 2006
Phindile Chauke


SONIA Makeleni was only 18 when she was forced to give up her ambitions of becoming an air hostess and an international model.

Diagnosed with tuberculosis four years ago when she was still at high school, Makeleni defaulted on her medication and, about a year later, her health deteriorated. Eventually she was told she had the multi-drug-resistant (MDR) strain of TB.

As she spoke to the Sunday Times at her family home in Albertsdal, south of Johannesburg, this week, Makeleni's bubbly personality made up for her fragile frame.

When she was diagnosed with MDR-TB Makeleni was studying in the field of tourism and faced the prospect of a UK modelling contract. But her health deteriorated after she had completed only one big advertisement - a Coca-Cola billboard.

She quickly lost too much weight and that put paid to her dream of being a cover girl.

Her TB-induced "anorexic" body sparked rumours in her neighbourhood that she was HIV-positive.

"I vomit all the time, cough and simply don't have an appetite. I sometimes cannot sleep because I cough all night," she said

Since being diagnosed with MDR-TB she takes between 13 and 19 pills a day. This is not pleasant, but she knows that unless she takes the cocktail diligently every day, she could develop the deadly form of the disease, XDR-TB.

This week, for the first time, the World Health Organisation (WHO) issued a warning about the killer strain, which has already killed dozens in South Africa.

A recent survey on XDR-TB cases in rural KwaZulu-Natal carried out by the WHO and the US Centres for Disease Control and Prevention found a high death rate among those diagnosed.

The study of 544 patients found that 221 had MDR-TB, the strain Makeleni suffers from.

Of these, 53 developed XDR-TB. (Forty-four of them had tested positive for HIV.)

Only one of the 53 survived - the rest died within 25 days of being diagnosed with the killer strain.

Since the survey, more people have died from XDR-TB, which it is feared might spread westwards through the Eastern Cape and beyond.

Makeleni considers herself lucky because she is not HIV-positive - those with the Aids virus are at greater risk of contracting the deadly strain of TB because of their compromised immune systems. Still, the drugs have affected her hearing.

When news of XDR-TB broke this week, Makeleni was relieved - she hoped that finally people would accept that she is not HIV-positive.

But she is petrified of getting sicker and of being bedridden again.

"All I wish for now is that they soon find the right drugs. I want to get better, to have a normal life."


060910
ST060904


Copyright © 2006 - The Sunday Times. Reproduction of this article (other than one copy for personal reference) must be cleared through the Sunday Times Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .